Abbott Laboratories wearables with a biosensor are performing well with consumers in the United Kingdom, a test market that precedes an eventual U.S. regulatory filing before the end of this year.
Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch
